National Graham Number from 2010 to 2026

NHC Stock  USD 169.69  1.36  0.81%   
National HealthCare's Graham Number is increasing over the years with slightly volatile fluctuation. Overall, Graham Number is expected to go to 92.04 this year. During the period from 2010 to 2026 National HealthCare Graham Number annual values regression line had geometric mean of  65.85 and mean square error of  300.44. View All Fundamentals
 
Graham Number  
First Reported
2010-12-31
Previous Quarter
87.66
Current Value
92.04
Quarterly Volatility
20.43522927
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
Check National HealthCare financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among National HealthCare's main balance sheet or income statement drivers, such as Depreciation And Amortization of 26.7 M, Interest Expense of 5 M or Total Revenue of 1.6 B, as well as many indicators such as Price To Sales Ratio of 0.64, Dividend Yield of 0.0244 or PTB Ratio of 1.96. National financial statements analysis is a perfect complement when working with National HealthCare Valuation or Volatility modules.
  
Build AI portfolio with National Stock
Check out the analysis of National HealthCare Correlation against competitors.
For information on how to trade National Stock refer to our How to Trade National Stock guide.
Analyzing National HealthCare's Graham Number over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Graham Number has evolved provides context for assessing National HealthCare's current valuation and future prospects.

Latest National HealthCare's Graham Number Growth Pattern

Below is the plot of the Graham Number of National HealthCare over the last few years. It is National HealthCare's Graham Number historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in National HealthCare's overall financial position and show how it may be relating to other accounts over time.
Graham Number10 Years Trend
Slightly volatile
   Graham Number   
       Timeline  

National Graham Number Regression Statistics

Arithmetic Mean69.38
Geometric Mean65.85
Coefficient Of Variation29.45
Mean Deviation14.24
Median67.96
Standard Deviation20.44
Sample Variance417.60
Range87.6237
R-Value0.57
Mean Square Error300.44
R-Squared0.33
Significance0.02
Slope2.31
Total Sum of Squares6,682

National Graham Number History

2026 92.04
2025 87.66
2024 97.4
2023 76.33
2022 43.12
2021 109.34
2020 56.55

About National HealthCare Financial Statements

National HealthCare stakeholders use historical fundamental indicators, such as National HealthCare's Graham Number, to determine how well the company is positioned to perform in the future. Although National HealthCare investors may analyze each financial statement separately, they are all interrelated. For example, changes in National HealthCare's assets and liabilities are reflected in the revenues and expenses on National HealthCare's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in National HealthCare. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Graham Number 87.66  92.04 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether National HealthCare offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of National HealthCare's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of National Healthcare Stock. Outlined below are crucial reports that will aid in making a well-informed decision on National Healthcare Stock:
Check out the analysis of National HealthCare Correlation against competitors.
For information on how to trade National Stock refer to our How to Trade National Stock guide.
You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Will Health Care Providers & Services sector continue expanding? Could National diversify its offerings? Factors like these will boost the valuation of National HealthCare. Anticipated expansion of National directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every National HealthCare data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth
(0.08)
Dividend Share
2.5
Earnings Share
6.48
Revenue Per Share
97.118
Quarterly Revenue Growth
0.125
The market value of National HealthCare is measured differently than its book value, which is the value of National that is recorded on the company's balance sheet. Investors also form their own opinion of National HealthCare's value that differs from its market value or its book value, called intrinsic value, which is National HealthCare's true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because National HealthCare's market value can be influenced by many factors that don't directly affect National HealthCare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between National HealthCare's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding National HealthCare should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, National HealthCare's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.